Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018

Los Angeles, CA, November 27, 2018 –(PRWirePro.com)– Medifocus, Inc. (OTCQB:MDFZF) and (TSX-V:MFS) (“Medifocus” or the “Company”), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, reported a 26% increase in revenue for the quarter ending September 30, 2018, and a 14% increase for the six months ending September 30, 2018, compared to the same periods in 2017.

VIEW FULL PRESS RELEASE